Trials / Completed
CompletedNCT01466634
Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis
Bioabsorbable Versus Permanent Polymer Bare Metal Stents in Saphenous Vein Graft Disease: Insights From a Meta-analysis of 6221 Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,221 (actual)
- Sponsor
- Azienda Ospedaliero Universitaria Maggiore della Carita · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Evidence supporting use of bioabsorbable polymer drug eluting stents (BP-DES) is uncertain. Thus the investigators planned a meta-analysis to compare outcomes of BP-DES versus PP-DES in obstructive coronary artery disease.
Detailed description
Evidence supporting use of bioabsorbable polymer drug eluting stents (BP-DES) is uncertain. Previous studies suggested that BP-DES are at least as effective as durable polymer drug eluting stents (PP-DES). Thus the investigators planned a meta-analysis to compare outcomes of BP-DES versus PP-DES in obstructive coronary artery disease. Medline and Web databases were searched for studies comparing BP-DES and PP-DES for obstructive coronary disease, reporting rates of overall mortality, target lesion revascularization (TLR), myocardial infarction (MI), binary restenosis and late lumen loss (LLL) with a follow-up ≥ 6 months. Odds ratios (ORs) will be computed from individual studies and pooled according to a fixed effect (e.g. inverse variance weighting) or random effect model in case of statistical heterogeneity. Given the a priori heterogeneous nature of the observational analyses, separate subgroup analysis of studies with PLA bioabsorbable polymer loaded with biolimus A19 (BP-BES) is prespecified.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | percutaneous coronary intervention with stent | patients with coronary artery disease treated by percutaneous coronary intervention with BP-DES are compared with patients with coronary artery disease treated by percutaneous coronary intervention with PP-DES |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-09-01
- Completion
- 2011-10-01
- First posted
- 2011-11-08
- Last updated
- 2011-11-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01466634. Inclusion in this directory is not an endorsement.